

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | diaphragm development (GO:0060539) | 6.16680637 |
| 2 | pyrimidine-containing compound salvage (GO:0008655) | 6.08445439 |
| 3 | pyrimidine nucleoside salvage (GO:0043097) | 6.08445439 |
| 4 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.66124420 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.64940263 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.64940263 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.64940263 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.64940263 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 5.64940263 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.64940263 |
| 11 | skeletal muscle organ development (GO:0060538) | 5.31142150 |
| 12 | cellular protein complex localization (GO:0034629) | 5.25532887 |
| 13 | activation of MAPKKK activity (GO:0000185) | 5.12517694 |
| 14 | positive regulation of cell size (GO:0045793) | 4.98247883 |
| 15 | protein localization to endosome (GO:0036010) | 4.55483502 |
| 16 | nucleotide salvage (GO:0043173) | 4.50918390 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.26041758 |
| 18 | positive regulation of interferon-alpha production (GO:0032727) | 4.22051251 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.21453270 |
| 20 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 4.14375415 |
| 21 | UMP biosynthetic process (GO:0006222) | 4.14375415 |
| 22 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 4.14375415 |
| 23 | UMP metabolic process (GO:0046049) | 4.14375415 |
| 24 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.05023525 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 4.04695272 |
| 26 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.99433773 |
| 27 | regulation of interferon-alpha production (GO:0032647) | 3.96627073 |
| 28 | positive regulation of antigen processing and presentation (GO:0002579) | 3.93406234 |
| 29 | arginine catabolic process (GO:0006527) | 3.93296396 |
| 30 | nucleoside salvage (GO:0043174) | 3.87194945 |
| 31 | neutrophil activation involved in immune response (GO:0002283) | 3.86054064 |
| 32 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.81594911 |
| 33 | mannose metabolic process (GO:0006013) | 3.78766091 |
| 34 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.77650188 |
| 35 | protein complex localization (GO:0031503) | 3.71850242 |
| 36 | pinocytosis (GO:0006907) | 3.71210160 |
| 37 | regulation of cholesterol storage (GO:0010885) | 3.67816599 |
| 38 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.67495307 |
| 39 | adenine nucleotide transport (GO:0051503) | 3.66689025 |
| 40 | low-density lipoprotein particle clearance (GO:0034383) | 3.66370505 |
| 41 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 3.66174585 |
| 42 | negative regulation of vascular permeability (GO:0043116) | 3.65548805 |
| 43 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.64718054 |
| 44 | apoptotic cell clearance (GO:0043277) | 3.59198994 |
| 45 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.54453865 |
| 46 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.53326110 |
| 47 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.50432079 |
| 48 | glycosphingolipid catabolic process (GO:0046479) | 3.47946955 |
| 49 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.47864744 |
| 50 | natural killer cell mediated immunity (GO:0002228) | 3.47864744 |
| 51 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.43997548 |
| 52 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.39270599 |
| 53 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.39270599 |
| 54 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.37794666 |
| 55 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 3.35874083 |
| 56 | regulation of integrin activation (GO:0033623) | 3.33083899 |
| 57 | B cell receptor signaling pathway (GO:0050853) | 3.32387303 |
| 58 | amino sugar catabolic process (GO:0046348) | 3.30707291 |
| 59 | negative regulation of alcohol biosynthetic process (GO:1902931) | 3.30356582 |
| 60 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.27385629 |
| 61 | NIK/NF-kappaB signaling (GO:0038061) | 3.24475983 |
| 62 | regulation of antigen processing and presentation (GO:0002577) | 3.22585857 |
| 63 | adhesion of symbiont to host (GO:0044406) | 3.22308796 |
| 64 | positive regulation of B cell differentiation (GO:0045579) | 3.20192311 |
| 65 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.19033898 |
| 66 | phagosome maturation (GO:0090382) | 3.17734411 |
| 67 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.17652520 |
| 68 | B cell mediated immunity (GO:0019724) | 3.17268567 |
| 69 | response to host immune response (GO:0052572) | 3.15980773 |
| 70 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.15980773 |
| 71 | response to thyroid hormone (GO:0097066) | 3.14181691 |
| 72 | positive regulation of interferon-beta production (GO:0032728) | 3.11210299 |
| 73 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.10847657 |
| 74 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.08915248 |
| 75 | regulation of monocyte differentiation (GO:0045655) | 3.08277802 |
| 76 | adhesion of symbiont to host cell (GO:0044650) | 3.07934885 |
| 77 | virion attachment to host cell (GO:0019062) | 3.07934885 |
| 78 | glycolipid catabolic process (GO:0019377) | 3.07531883 |
| 79 | negative regulation of macrophage differentiation (GO:0045650) | 3.06778644 |
| 80 | I-kappaB phosphorylation (GO:0007252) | 3.06208782 |
| 81 | respiratory burst (GO:0045730) | 3.05993736 |
| 82 | purine ribonucleotide transport (GO:0015868) | 3.03773858 |
| 83 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.02836099 |
| 84 | response to nerve growth factor (GO:1990089) | 3.02148744 |
| 85 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.02148744 |
| 86 | barbed-end actin filament capping (GO:0051016) | 2.99545510 |
| 87 | response to host defenses (GO:0052200) | 2.99007387 |
| 88 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.99007387 |
| 89 | response to host (GO:0075136) | 2.99007387 |
| 90 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.97806797 |
| 91 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.97335597 |
| 92 | cytidine deamination (GO:0009972) | 2.96392575 |
| 93 | cytidine metabolic process (GO:0046087) | 2.96392575 |
| 94 | cytidine catabolic process (GO:0006216) | 2.96392575 |
| 95 | regulation of mononuclear cell migration (GO:0071675) | 2.96340840 |
| 96 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.95636417 |
| 97 | lipoprotein transport (GO:0042953) | 2.93784027 |
| 98 | purine nucleotide transport (GO:0015865) | 2.93082222 |
| 99 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.92601443 |
| 100 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.92051829 |
| 101 | oligosaccharide catabolic process (GO:0009313) | 2.91929942 |
| 102 | protein heterotrimerization (GO:0070208) | 2.88411997 |
| 103 | hypotonic response (GO:0006971) | 2.88219548 |
| 104 | myeloid dendritic cell differentiation (GO:0043011) | 2.85502572 |
| 105 | ncRNA 3-end processing (GO:0043628) | 2.83848699 |
| 106 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.83601148 |
| 107 | negative regulation of interleukin-12 production (GO:0032695) | 2.82684286 |
| 108 | response to muramyl dipeptide (GO:0032495) | 2.81040687 |
| 109 | cellular response to arsenic-containing substance (GO:0071243) | 2.80270763 |
| 110 | modulation by symbiont of host cellular process (GO:0044068) | 2.79720748 |
| 111 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.79091034 |
| 112 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.78635519 |
| 113 | regulation of early endosome to late endosome transport (GO:2000641) | 2.77471944 |
| 114 | negative regulation of granulocyte differentiation (GO:0030853) | 2.77104812 |
| 115 | positive regulation of T cell apoptotic process (GO:0070234) | 2.76271182 |
| 116 | positive regulation of p38MAPK cascade (GO:1900745) | 2.71904901 |
| 117 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.71866500 |
| 118 | negative regulation of interleukin-2 production (GO:0032703) | 2.71063406 |
| 119 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.70871366 |
| 120 | nitric oxide biosynthetic process (GO:0006809) | 2.70707287 |
| 121 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.69559086 |
| 122 | mRNA stabilization (GO:0048255) | 2.66836355 |
| 123 | RNA stabilization (GO:0043489) | 2.66836355 |
| 124 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.64314414 |
| 125 | granulocyte activation (GO:0036230) | 2.63442915 |
| 126 | neutrophil activation (GO:0042119) | 2.62219692 |
| 127 | membrane lipid catabolic process (GO:0046466) | 2.61653368 |
| 128 | pentose-phosphate shunt (GO:0006098) | 2.61341290 |
| 129 | negative regulation of cell size (GO:0045792) | 2.61141930 |
| 130 | ceramide catabolic process (GO:0046514) | 2.59643814 |
| 131 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.58820599 |
| 132 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.58800114 |
| 133 | Rap protein signal transduction (GO:0032486) | 2.57671875 |
| 134 | arginine metabolic process (GO:0006525) | 2.57633252 |
| 135 | negative regulation of protein kinase B signaling (GO:0051898) | 2.56344183 |
| 136 | regulation of superoxide anion generation (GO:0032928) | 2.55683912 |
| 137 | sphingolipid catabolic process (GO:0030149) | 2.54866076 |
| 138 | basic amino acid transport (GO:0015802) | 2.53825267 |
| 139 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.53344665 |
| 140 | T-helper 1 type immune response (GO:0042088) | 2.52632829 |
| 141 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.52360459 |
| 142 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.52017614 |
| 143 | regulation of interferon-beta production (GO:0032648) | 2.51831373 |
| 144 | response to laminar fluid shear stress (GO:0034616) | 2.51289157 |
| 145 | positive regulation of leukocyte degranulation (GO:0043302) | 2.50969632 |
| 146 | negative regulation of interleukin-6 production (GO:0032715) | 2.50131811 |
| 147 | cell adhesion mediated by integrin (GO:0033627) | 2.50041415 |
| 148 | hyaluronan catabolic process (GO:0030214) | 2.49783490 |
| 149 | myeloid cell homeostasis (GO:0002262) | 2.49645838 |
| 150 | endocytic recycling (GO:0032456) | 2.49114339 |
| 151 | regulation of B cell differentiation (GO:0045577) | 2.48914487 |
| 152 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.47752595 |
| 153 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.47454214 |
| 154 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.47399973 |
| 155 | response to peptidoglycan (GO:0032494) | 2.46943396 |
| 156 | regulation of oxidative phosphorylation (GO:0002082) | 2.46727521 |
| 157 | macrophage activation (GO:0042116) | 2.46661829 |
| 158 | negative regulation of ERBB signaling pathway (GO:1901185) | 2.46324962 |
| 159 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.45803809 |
| 160 | urea cycle (GO:0000050) | 2.45232691 |
| 161 | regulation of mitochondrial translation (GO:0070129) | 2.44377659 |
| 162 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.43820101 |
| 163 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.43533711 |
| 164 | apoptotic process involved in morphogenesis (GO:0060561) | 2.42981198 |
| 165 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.42322040 |
| 166 | keratan sulfate catabolic process (GO:0042340) | 2.42141732 |
| 167 | response to lipoprotein particle (GO:0055094) | 2.41329633 |
| 168 | lymphocyte mediated immunity (GO:0002449) | 2.41306187 |
| 169 | NADPH regeneration (GO:0006740) | 2.40692133 |
| 170 | positive regulation of bone resorption (GO:0045780) | 2.39728933 |
| 171 | positive regulation of bone remodeling (GO:0046852) | 2.39728933 |
| 172 | regulation of gamma-delta T cell activation (GO:0046643) | 2.39711899 |
| 173 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.38731883 |
| 174 | neutrophil mediated immunity (GO:0002446) | 2.37603223 |
| 175 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.37174168 |
| 176 | maternal placenta development (GO:0001893) | 2.36928986 |
| 177 | T cell apoptotic process (GO:0070231) | 2.36776061 |
| 178 | leukocyte mediated cytotoxicity (GO:0001909) | 2.35976739 |
| 179 | myeloid cell activation involved in immune response (GO:0002275) | 2.31259225 |
| 180 | positive regulation of lipid storage (GO:0010884) | 2.28732419 |
| 181 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.27408362 |
| 182 | negative regulation of B cell proliferation (GO:0030889) | 2.26797006 |
| 183 | negative regulation of lipid storage (GO:0010888) | 2.26776981 |
| 184 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.26756353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.61771681 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.55711758 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.17497384 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.02792585 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.77036690 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.69480387 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.64103290 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.60780172 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.56708496 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.51657289 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42343816 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.36356829 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30840603 |
| 14 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.23854064 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.03527029 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.02725667 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.00183746 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.95322191 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.93823067 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90059632 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.89917204 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.87709070 |
| 23 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.84644632 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.82983404 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.79899455 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.78434967 |
| 27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.77735268 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.76356593 |
| 29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.71875219 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71533212 |
| 31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.63496716 |
| 32 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63461340 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61874851 |
| 34 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.58162822 |
| 35 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.56699500 |
| 36 | KDM2B_26808549_Chip-Seq_K562_Human | 1.56212527 |
| 37 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.54910101 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54278443 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.53748891 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.53413362 |
| 41 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49729643 |
| 42 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.47021760 |
| 43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46945844 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.43493855 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42836510 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41551552 |
| 47 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.37293679 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36403701 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36203964 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35617935 |
| 51 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.34452006 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.34162772 |
| 53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32175999 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31837081 |
| 55 | * P68_20966046_ChIP-Seq_HELA_Human | 1.30333582 |
| 56 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.30206847 |
| 57 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29856824 |
| 58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29245037 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26850383 |
| 60 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.25899971 |
| 61 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24804336 |
| 62 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.23842656 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23411814 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22920814 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21166950 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20741965 |
| 67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20714166 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20096697 |
| 69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19861193 |
| 70 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.19385802 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19215890 |
| 72 | MYB_26560356_Chip-Seq_TH1_Human | 1.17311987 |
| 73 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17135410 |
| 74 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16664701 |
| 75 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15749862 |
| 76 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.14758847 |
| 77 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14166475 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13787395 |
| 79 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13731375 |
| 80 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13685242 |
| 81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.13463545 |
| 82 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.13114485 |
| 83 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12699708 |
| 84 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11659055 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10735920 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09874277 |
| 87 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09856595 |
| 88 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08596908 |
| 89 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08302133 |
| 90 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08272734 |
| 91 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.08145290 |
| 92 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.07959261 |
| 93 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07896925 |
| 94 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.07064063 |
| 95 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06841997 |
| 96 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06836213 |
| 97 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06813297 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06487009 |
| 99 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06237479 |
| 100 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.05767343 |
| 101 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.05000162 |
| 102 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04259256 |
| 103 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04245308 |
| 104 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03864176 |
| 105 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03321906 |
| 106 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03246447 |
| 107 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02986766 |
| 108 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02806351 |
| 109 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02726847 |
| 110 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02366262 |
| 111 | MAF_26560356_Chip-Seq_TH2_Human | 1.01836744 |
| 112 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.01514513 |
| 113 | MYB_26560356_Chip-Seq_TH2_Human | 1.01258636 |
| 114 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00492959 |
| 115 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.98749233 |
| 116 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98015421 |
| 117 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97470282 |
| 118 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96887644 |
| 119 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.96139677 |
| 120 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.96015084 |
| 121 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95807294 |
| 122 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94989393 |
| 123 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94517517 |
| 124 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94314619 |
| 125 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94078452 |
| 126 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93803259 |
| 127 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.93267220 |
| 128 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.92760331 |
| 129 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90749432 |
| 130 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89968212 |
| 131 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88702933 |
| 132 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.88244414 |
| 133 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87226670 |
| 134 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86873308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.31122580 |
| 2 | MP0009840_abnormal_foam_cell | 3.93005197 |
| 3 | MP0003646_muscle_fatigue | 3.77407033 |
| 4 | MP0004233_abnormal_muscle_weight | 3.70758445 |
| 5 | MP0004858_abnormal_nervous_system | 3.50875847 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.20142158 |
| 7 | MP0003303_peritoneal_inflammation | 3.11715021 |
| 8 | MP0000569_abnormal_digit_pigmentation | 3.07118236 |
| 9 | MP0000566_synostosis | 3.04621686 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.92251701 |
| 11 | MP0005167_abnormal_blood-brain_barrier | 2.88724274 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.57489410 |
| 13 | MP0005257_abnormal_intraocular_pressure | 2.39376169 |
| 14 | MP0001790_abnormal_immune_system | 2.31907815 |
| 15 | MP0005387_immune_system_phenotype | 2.31907815 |
| 16 | MP0000685_abnormal_immune_system | 2.29093218 |
| 17 | MP0003436_decreased_susceptibility_to | 2.27038827 |
| 18 | MP0001800_abnormal_humoral_immune | 2.10582487 |
| 19 | MP0003075_altered_response_to | 2.10288702 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.07495583 |
| 21 | MP0006082_CNS_inflammation | 2.05016194 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.01468989 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.99536053 |
| 24 | MP0010307_abnormal_tumor_latency | 1.94960392 |
| 25 | MP0004510_myositis | 1.94147433 |
| 26 | MP0002419_abnormal_innate_immunity | 1.93762887 |
| 27 | MP0003566_abnormal_cell_adhesion | 1.89864781 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.84926500 |
| 29 | MP0010368_abnormal_lymphatic_system | 1.82065718 |
| 30 | MP0002254_reproductive_system_inflammat | 1.81959288 |
| 31 | MP0000343_altered_response_to | 1.71711118 |
| 32 | MP0009278_abnormal_bone_marrow | 1.63962631 |
| 33 | MP0005076_abnormal_cell_differentiation | 1.63615082 |
| 34 | MP0008438_abnormal_cutaneous_collagen | 1.61627406 |
| 35 | MP0009053_abnormal_anal_canal | 1.58934572 |
| 36 | MP0002234_abnormal_pharynx_morphology | 1.58091995 |
| 37 | MP0002723_abnormal_immune_serum | 1.57828924 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.55145373 |
| 39 | MP0005025_abnormal_response_to | 1.48333773 |
| 40 | MP0000604_amyloidosis | 1.47819823 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.46783466 |
| 42 | MP0001819_abnormal_immune_cell | 1.45642067 |
| 43 | MP0004947_skin_inflammation | 1.45517583 |
| 44 | MP0002420_abnormal_adaptive_immunity | 1.45352873 |
| 45 | MP0003045_fibrosis | 1.45156500 |
| 46 | MP0009764_decreased_sensitivity_to | 1.42855153 |
| 47 | MP0004043_abnormal_pH_regulation | 1.42769085 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.40481902 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.38358423 |
| 50 | MP0001958_emphysema | 1.38097852 |
| 51 | MP0003448_altered_tumor_morphology | 1.33904037 |
| 52 | MP0005360_urolithiasis | 1.31876532 |
| 53 | MP0000371_diluted_coat_color | 1.31284782 |
| 54 | MP0002405_respiratory_system_inflammati | 1.30075513 |
| 55 | MP0005310_abnormal_salivary_gland | 1.28464620 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.26750488 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.26663108 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.25669189 |
| 59 | MP0000490_abnormal_crypts_of | 1.22463282 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.21334480 |
| 61 | MP0005166_decreased_susceptibility_to | 1.20775960 |
| 62 | MP0000716_abnormal_immune_system | 1.20047793 |
| 63 | MP0002136_abnormal_kidney_physiology | 1.19155539 |
| 64 | MP0005645_abnormal_hypothalamus_physiol | 1.17447986 |
| 65 | MP0002722_abnormal_immune_system | 1.14954954 |
| 66 | MP0002398_abnormal_bone_marrow | 1.14811839 |
| 67 | MP0002148_abnormal_hypersensitivity_rea | 1.14526893 |
| 68 | MP0003111_abnormal_nucleus_morphology | 1.12512686 |
| 69 | MP0009643_abnormal_urine_homeostasis | 1.10517620 |
| 70 | MP0008469_abnormal_protein_level | 1.09845263 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.09687404 |
| 72 | MP0003279_aneurysm | 1.08384267 |
| 73 | MP0000609_abnormal_liver_physiology | 1.07715830 |
| 74 | MP0002429_abnormal_blood_cell | 1.07245277 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 1.05814088 |
| 76 | MP0003091_abnormal_cell_migration | 1.04032094 |
| 77 | MP0001873_stomach_inflammation | 1.02047565 |
| 78 | MP0000015_abnormal_ear_pigmentation | 1.00642589 |
| 79 | MP0001756_abnormal_urination | 0.99358017 |
| 80 | MP0005023_abnormal_wound_healing | 0.96979319 |
| 81 | MP0001849_ear_inflammation | 0.94586587 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 0.93654671 |
| 83 | MP0009785_altered_susceptibility_to | 0.92390689 |
| 84 | MP0003690_abnormal_glial_cell | 0.91735421 |
| 85 | MP0005670_abnormal_white_adipose | 0.91369258 |
| 86 | MP0004019_abnormal_vitamin_homeostasis | 0.91187365 |
| 87 | MP0003693_abnormal_embryo_hatching | 0.90979571 |
| 88 | MP0001853_heart_inflammation | 0.90902032 |
| 89 | MP0005671_abnormal_response_to | 0.90283522 |
| 90 | MP0003195_calcinosis | 0.90251013 |
| 91 | MP0000598_abnormal_liver_morphology | 0.89963751 |
| 92 | MP0005083_abnormal_biliary_tract | 0.89000168 |
| 93 | MP0005197_abnormal_uvea_morphology | 0.88475723 |
| 94 | MP0000467_abnormal_esophagus_morphology | 0.88048144 |
| 95 | MP0000858_altered_metastatic_potential | 0.87861153 |
| 96 | MP0003077_abnormal_cell_cycle | 0.87816184 |
| 97 | MP0001915_intracranial_hemorrhage | 0.85450721 |
| 98 | MP0008874_decreased_physiological_sensi | 0.84298735 |
| 99 | MP0002998_abnormal_bone_remodeling | 0.83859988 |
| 100 | MP0002396_abnormal_hematopoietic_system | 0.83651558 |
| 101 | MP0002139_abnormal_hepatobiliary_system | 0.83605958 |
| 102 | MP0002166_altered_tumor_susceptibility | 0.82390551 |
| 103 | MP0005174_abnormal_tail_pigmentation | 0.81862059 |
| 104 | MP0005332_abnormal_amino_acid | 0.81527497 |
| 105 | MP0000733_abnormal_muscle_development | 0.81421535 |
| 106 | MP0005390_skeleton_phenotype | 0.81221013 |
| 107 | MP0002135_abnormal_kidney_morphology | 0.79667906 |
| 108 | MP0005451_abnormal_body_composition | 0.78466749 |
| 109 | MP0005397_hematopoietic_system_phenotyp | 0.76771702 |
| 110 | MP0001545_abnormal_hematopoietic_system | 0.76771702 |
| 111 | MP0005621_abnormal_cell_physiology | 0.76211239 |
| 112 | MP0003634_abnormal_glial_cell | 0.74981506 |
| 113 | MP0001730_embryonic_growth_arrest | 0.74917947 |
| 114 | MP0002113_abnormal_skeleton_development | 0.74504231 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.74447436 |
| 116 | MP0005171_absent_coat_pigmentation | 0.72518471 |
| 117 | MP0008260_abnormal_autophagy | 0.72317334 |
| 118 | MP0000350_abnormal_cell_proliferation | 0.70413662 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.69906346 |
| 120 | MP0010329_abnormal_lipoprotein_level | 0.69776397 |
| 121 | MP0003763_abnormal_thymus_physiology | 0.69345603 |
| 122 | MP0002933_joint_inflammation | 0.68296991 |
| 123 | MP0003329_amyloid_beta_deposits | 0.68205752 |
| 124 | MP0000358_abnormal_cell_content/ | 0.67997948 |
| 125 | MP0003283_abnormal_digestive_organ | 0.67759198 |
| 126 | MP0004883_abnormal_blood_vessel | 0.67668379 |
| 127 | MP0000750_abnormal_muscle_regeneration | 0.67416582 |
| 128 | MP0005164_abnormal_response_to | 0.67007931 |
| 129 | MP0003656_abnormal_erythrocyte_physiolo | 0.65708294 |
| 130 | MP0001851_eye_inflammation | 0.65707016 |
| 131 | MP0001663_abnormal_digestive_system | 0.65696875 |
| 132 | MP0002019_abnormal_tumor_incidence | 0.65053041 |
| 133 | MP0000767_abnormal_smooth_muscle | 0.63561647 |
| 134 | MP0010155_abnormal_intestine_physiology | 0.61132184 |
| 135 | MP0003828_pulmonary_edema | 0.58362317 |
| 136 | MP0002089_abnormal_postnatal_growth/wei | 0.57292004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 5.08286186 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 4.76049476 |
| 3 | Sparse lateral eyebrow (HP:0005338) | 4.68916577 |
| 4 | Dysostosis multiplex (HP:0000943) | 4.40393991 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.34236522 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.13482698 |
| 7 | Lip pit (HP:0100267) | 3.84403480 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.83378842 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.83131551 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.83131551 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.83131551 |
| 12 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.82930656 |
| 13 | Mucopolysacchariduria (HP:0008155) | 3.82930656 |
| 14 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.66193151 |
| 15 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.66193151 |
| 16 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.66193151 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.65434305 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.63274501 |
| 19 | Anal stenosis (HP:0002025) | 3.60193559 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.51261357 |
| 21 | Loss of speech (HP:0002371) | 3.48176147 |
| 22 | Ureteral stenosis (HP:0000071) | 3.48013215 |
| 23 | Axonal loss (HP:0003447) | 3.41429363 |
| 24 | Intestinal fistula (HP:0100819) | 3.37741026 |
| 25 | Abnormality of the fingertips (HP:0001211) | 3.31120419 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.29906992 |
| 27 | Disinhibition (HP:0000734) | 3.19737531 |
| 28 | Progressive neurologic deterioration (HP:0002344) | 3.18226588 |
| 29 | Ureteral obstruction (HP:0006000) | 3.17140055 |
| 30 | Global brain atrophy (HP:0002283) | 3.07423623 |
| 31 | Myocardial infarction (HP:0001658) | 3.07316065 |
| 32 | Natal tooth (HP:0000695) | 3.01198732 |
| 33 | Colitis (HP:0002583) | 2.98939690 |
| 34 | Long palpebral fissure (HP:0000637) | 2.98769635 |
| 35 | Cellulitis (HP:0100658) | 2.94850844 |
| 36 | Cerebral aneurysm (HP:0004944) | 2.89141198 |
| 37 | Short 5th finger (HP:0009237) | 2.89043633 |
| 38 | Hand muscle atrophy (HP:0009130) | 2.82483891 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.77223255 |
| 40 | Lower limb hyperreflexia (HP:0002395) | 2.76647059 |
| 41 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.75387511 |
| 42 | Nuclear cataract (HP:0100018) | 2.74667750 |
| 43 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.74203601 |
| 44 | Upper motor neuron abnormality (HP:0002127) | 2.65245681 |
| 45 | Glomerulonephritis (HP:0000099) | 2.61663824 |
| 46 | Asymmetric septal hypertrophy (HP:0001670) | 2.58657892 |
| 47 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 2.58657563 |
| 48 | Recurrent skin infections (HP:0001581) | 2.57614309 |
| 49 | Trismus (HP:0000211) | 2.56705558 |
| 50 | Pathologic fracture (HP:0002756) | 2.53491460 |
| 51 | Abnormality of the periventricular white matter (HP:0002518) | 2.53461821 |
| 52 | Depressed nasal tip (HP:0000437) | 2.52970882 |
| 53 | Gingivitis (HP:0000230) | 2.51864192 |
| 54 | Distal upper limb amyotrophy (HP:0007149) | 2.48076122 |
| 55 | Upper limb amyotrophy (HP:0009129) | 2.48076122 |
| 56 | Personality changes (HP:0000751) | 2.47763214 |
| 57 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.45716009 |
| 58 | Emphysema (HP:0002097) | 2.43165412 |
| 59 | Petechiae (HP:0000967) | 2.39755511 |
| 60 | Hyperacusis (HP:0010780) | 2.38929262 |
| 61 | Pustule (HP:0200039) | 2.37075117 |
| 62 | Tetraparesis (HP:0002273) | 2.36532257 |
| 63 | Recurrent fungal infections (HP:0002841) | 2.34154303 |
| 64 | Hypertensive crisis (HP:0100735) | 2.33476576 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.31137193 |
| 66 | Agnosia (HP:0010524) | 2.29508486 |
| 67 | Gastrointestinal stroma tumor (HP:0100723) | 2.28370841 |
| 68 | Peripheral demyelination (HP:0011096) | 2.27757479 |
| 69 | Osteomyelitis (HP:0002754) | 2.26338773 |
| 70 | Hematochezia (HP:0002573) | 2.24913660 |
| 71 | Mediastinal lymphadenopathy (HP:0100721) | 2.24461195 |
| 72 | Achilles tendon contracture (HP:0001771) | 2.21344680 |
| 73 | Osteolytic defects of the hand bones (HP:0009699) | 2.21084431 |
| 74 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.21084431 |
| 75 | Vertebral hypoplasia (HP:0008417) | 2.19361934 |
| 76 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.19361934 |
| 77 | Recurrent viral infections (HP:0004429) | 2.19168792 |
| 78 | Inflammation of the large intestine (HP:0002037) | 2.18626815 |
| 79 | Cervical subluxation (HP:0003308) | 2.18135885 |
| 80 | Gastrointestinal inflammation (HP:0004386) | 2.16499957 |
| 81 | Posterior subcapsular cataract (HP:0007787) | 2.15096055 |
| 82 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.14767415 |
| 83 | Abnormality of complement system (HP:0005339) | 2.14372102 |
| 84 | Increased CSF protein (HP:0002922) | 2.13867595 |
| 85 | Vertebral compression fractures (HP:0002953) | 2.12139184 |
| 86 | Poor head control (HP:0002421) | 2.11351804 |
| 87 | Fatigue (HP:0012378) | 2.11318233 |
| 88 | Xanthomatosis (HP:0000991) | 2.08758938 |
| 89 | Agammaglobulinemia (HP:0004432) | 2.08192132 |
| 90 | Periodontitis (HP:0000704) | 2.05794351 |
| 91 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.02309086 |
| 92 | Thoracic kyphosis (HP:0002942) | 2.01775604 |
| 93 | Ulnar bowing (HP:0003031) | 2.01699401 |
| 94 | Polycythemia (HP:0001901) | 2.00062085 |
| 95 | Obstructive sleep apnea (HP:0002870) | 1.98036473 |
| 96 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.97457340 |
| 97 | Metaphyseal cupping (HP:0003021) | 1.96648814 |
| 98 | Neuronal loss in central nervous system (HP:0002529) | 1.95105381 |
| 99 | Neurofibrillary tangles (HP:0002185) | 1.94454866 |
| 100 | Abnormality of the Achilles tendon (HP:0005109) | 1.93783451 |
| 101 | Subcapsular cataract (HP:0000523) | 1.92266736 |
| 102 | J-shaped sella turcica (HP:0002680) | 1.91256509 |
| 103 | Bone pain (HP:0002653) | 1.90966167 |
| 104 | Mitral stenosis (HP:0001718) | 1.90653715 |
| 105 | Restrictive lung disease (HP:0002091) | 1.90510334 |
| 106 | Esophageal varix (HP:0002040) | 1.89259183 |
| 107 | Purpura (HP:0000979) | 1.89174172 |
| 108 | Cortical dysplasia (HP:0002539) | 1.88746897 |
| 109 | Conjunctival telangiectasia (HP:0000524) | 1.87569766 |
| 110 | Complement deficiency (HP:0004431) | 1.87138315 |
| 111 | Prolonged neonatal jaundice (HP:0006579) | 1.86756682 |
| 112 | Neonatal death (HP:0003811) | 1.86342130 |
| 113 | Papilloma (HP:0012740) | 1.86302867 |
| 114 | Verrucae (HP:0200043) | 1.86302867 |
| 115 | Renal cell carcinoma (HP:0005584) | 1.84961718 |
| 116 | Rough bone trabeculation (HP:0100670) | 1.83963935 |
| 117 | Increased serum ferritin (HP:0003281) | 1.83623672 |
| 118 | Nephritis (HP:0000123) | 1.80333299 |
| 119 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.78121201 |
| 120 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.77849645 |
| 121 | Recurrent cutaneous fungal infections (HP:0011370) | 1.77849645 |
| 122 | Ectropion (HP:0000656) | 1.76986299 |
| 123 | Abnormality of the thoracic spine (HP:0100711) | 1.76960148 |
| 124 | Diminished motivation (HP:0000745) | 1.75490128 |
| 125 | Increased connective tissue (HP:0009025) | 1.74423578 |
| 126 | Premature rupture of membranes (HP:0001788) | 1.74177495 |
| 127 | Popliteal pterygium (HP:0009756) | 1.73420216 |
| 128 | Uterine leiomyosarcoma (HP:0002891) | 1.72239201 |
| 129 | Leiomyosarcoma (HP:0100243) | 1.72239201 |
| 130 | Neurodegeneration (HP:0002180) | 1.71859671 |
| 131 | Hepatosplenomegaly (HP:0001433) | 1.71733015 |
| 132 | Mutism (HP:0002300) | 1.71066303 |
| 133 | Abnormality of iron homeostasis (HP:0011031) | 1.70846488 |
| 134 | Abnormality of the lumbar spine (HP:0100712) | 1.70838433 |
| 135 | Blue sclerae (HP:0000592) | 1.69374336 |
| 136 | Apathy (HP:0000741) | 1.69371242 |
| 137 | Vasculitis (HP:0002633) | 1.68685530 |
| 138 | Abnormal trabecular bone morphology (HP:0100671) | 1.68522378 |
| 139 | Cerebral inclusion bodies (HP:0100314) | 1.67897347 |
| 140 | Hypokinesia (HP:0002375) | 1.67819425 |
| 141 | Distal lower limb muscle weakness (HP:0009053) | 1.67494090 |
| 142 | Neonatal short-limb short stature (HP:0008921) | 1.67460046 |
| 143 | Nausea (HP:0002018) | 1.67322299 |
| 144 | Obstructive lung disease (HP:0006536) | 1.66633585 |
| 145 | Chronic obstructive pulmonary disease (HP:0006510) | 1.66633585 |
| 146 | Urticaria (HP:0001025) | 1.66561189 |
| 147 | Thin bony cortex (HP:0002753) | 1.66080010 |
| 148 | Gout (HP:0001997) | 1.65954973 |
| 149 | Spinal muscular atrophy (HP:0007269) | 1.65861486 |
| 150 | Advanced eruption of teeth (HP:0006288) | 1.65457071 |
| 151 | Distal lower limb amyotrophy (HP:0008944) | 1.65242917 |
| 152 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.64836027 |
| 153 | Premature loss of primary teeth (HP:0006323) | 1.62972918 |
| 154 | Mucosal telangiectasiae (HP:0100579) | 1.62819306 |
| 155 | Disproportionate tall stature (HP:0001519) | 1.62410568 |
| 156 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.59158297 |
| 157 | Recurrent pneumonia (HP:0006532) | 1.59103995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK24 | 5.57817505 |
| 2 | ERN1 | 3.92502131 |
| 3 | TRIB3 | 3.49453411 |
| 4 | CCNB1 | 3.01431769 |
| 5 | MAP4K1 | 2.87096894 |
| 6 | BLK | 2.63225956 |
| 7 | WNK4 | 2.57866048 |
| 8 | MAP3K10 | 2.56707948 |
| 9 | PRPF4B | 2.52530886 |
| 10 | STK39 | 2.46536761 |
| 11 | PKN2 | 2.42715012 |
| 12 | SCYL2 | 2.41269417 |
| 13 | MAP3K2 | 2.40957222 |
| 14 | TYK2 | 2.26218821 |
| 15 | TBK1 | 2.12172396 |
| 16 | KIT | 2.00310383 |
| 17 | BUB1 | 1.92400128 |
| 18 | ILK | 1.87119601 |
| 19 | TAOK2 | 1.86268219 |
| 20 | TTN | 1.82402042 |
| 21 | CSF1R | 1.78899644 |
| 22 | NEK2 | 1.78730492 |
| 23 | MAPKAPK3 | 1.75783541 |
| 24 | LRRK2 | 1.75659135 |
| 25 | CDK12 | 1.75091403 |
| 26 | PTK6 | 1.65534416 |
| 27 | MAP3K14 | 1.64049233 |
| 28 | STK10 | 1.63757158 |
| 29 | DDR2 | 1.63462285 |
| 30 | CAMK1D | 1.55244820 |
| 31 | TGFBR2 | 1.51232409 |
| 32 | MAP2K3 | 1.50055089 |
| 33 | GRK6 | 1.46984855 |
| 34 | IKBKB | 1.42636599 |
| 35 | IRAK3 | 1.39279835 |
| 36 | SMG1 | 1.39040758 |
| 37 | RPS6KA4 | 1.28974824 |
| 38 | RPS6KC1 | 1.28109459 |
| 39 | RPS6KL1 | 1.28109459 |
| 40 | MAP3K3 | 1.24715358 |
| 41 | JAK1 | 1.24703604 |
| 42 | EEF2K | 1.24657601 |
| 43 | EPHB1 | 1.24605092 |
| 44 | PAK4 | 1.20965989 |
| 45 | RIPK4 | 1.18554816 |
| 46 | BMX | 1.13935548 |
| 47 | PINK1 | 1.11627922 |
| 48 | NEK9 | 1.10842891 |
| 49 | BTK | 1.10689584 |
| 50 | KDR | 1.10194610 |
| 51 | NME2 | 1.08127289 |
| 52 | CHUK | 1.07911299 |
| 53 | RPS6KA6 | 1.07189366 |
| 54 | SYK | 1.07179144 |
| 55 | IRAK4 | 1.04042493 |
| 56 | ALK | 1.00189697 |
| 57 | SIK2 | 0.99709222 |
| 58 | ZAP70 | 0.99002722 |
| 59 | RIPK1 | 0.98745438 |
| 60 | CSK | 0.98621495 |
| 61 | MAP3K11 | 0.97948845 |
| 62 | SIK1 | 0.96359345 |
| 63 | JAK3 | 0.96309438 |
| 64 | PIM1 | 0.94489816 |
| 65 | MAP3K8 | 0.93516328 |
| 66 | HCK | 0.93283522 |
| 67 | FGFR4 | 0.92313103 |
| 68 | RPS6KA2 | 0.90071907 |
| 69 | CHEK2 | 0.89966930 |
| 70 | CAMK1G | 0.88113114 |
| 71 | MTOR | 0.87553866 |
| 72 | NEK1 | 0.87445033 |
| 73 | MAP3K13 | 0.86430076 |
| 74 | CDC42BPA | 0.86369689 |
| 75 | TESK2 | 0.86131488 |
| 76 | JAK2 | 0.85646396 |
| 77 | CDK4 | 0.84894087 |
| 78 | TAOK3 | 0.81614018 |
| 79 | CDK6 | 0.81229876 |
| 80 | MARK3 | 0.80462760 |
| 81 | BCKDK | 0.80189248 |
| 82 | CAMK4 | 0.78897953 |
| 83 | ARAF | 0.78778130 |
| 84 | EPHA2 | 0.78148549 |
| 85 | TRPM7 | 0.77827676 |
| 86 | LYN | 0.74865075 |
| 87 | RPS6KB2 | 0.74323202 |
| 88 | TAOK1 | 0.72461181 |
| 89 | WNK1 | 0.72160736 |
| 90 | DYRK1B | 0.70342395 |
| 91 | MST1R | 0.68886994 |
| 92 | EGFR | 0.66606814 |
| 93 | PRKCQ | 0.65898133 |
| 94 | GRK7 | 0.65457549 |
| 95 | FGFR3 | 0.65084161 |
| 96 | STK4 | 0.62973002 |
| 97 | CDK9 | 0.62835243 |
| 98 | PTK2 | 0.62649128 |
| 99 | ICK | 0.61850497 |
| 100 | MOS | 0.61599791 |
| 101 | LMTK2 | 0.61450185 |
| 102 | MATK | 0.59693373 |
| 103 | STK3 | 0.58759621 |
| 104 | IKBKE | 0.57017149 |
| 105 | CAMK1 | 0.56629840 |
| 106 | MAPK11 | 0.56435534 |
| 107 | IRAK2 | 0.52867340 |
| 108 | PAK2 | 0.50366408 |
| 109 | CDC7 | 0.50203676 |
| 110 | DYRK3 | 0.49615527 |
| 111 | LATS2 | 0.49312740 |
| 112 | FLT3 | 0.49190626 |
| 113 | PRKG2 | 0.48099510 |
| 114 | PIM2 | 0.47651655 |
| 115 | PDGFRA | 0.47282787 |
| 116 | DAPK3 | 0.47184631 |
| 117 | LCK | 0.47004519 |
| 118 | ABL1 | 0.46665237 |
| 119 | FGR | 0.45686066 |
| 120 | MAP3K1 | 0.44752023 |
| 121 | ABL2 | 0.43458815 |
| 122 | LIMK1 | 0.41906702 |
| 123 | PDPK1 | 0.41768586 |
| 124 | MAPKAPK5 | 0.40076255 |
| 125 | EIF2AK1 | 0.39380405 |
| 126 | WEE1 | 0.38641023 |
| 127 | KSR2 | 0.37261949 |
| 128 | MAP2K2 | 0.36931180 |
| 129 | EPHA3 | 0.36877314 |
| 130 | PRKCD | 0.36604174 |
| 131 | ITK | 0.35547951 |
| 132 | GSK3A | 0.34998912 |
| 133 | PAK1 | 0.34599639 |
| 134 | TESK1 | 0.34290241 |
| 135 | PLK1 | 0.33154344 |
| 136 | FES | 0.32721427 |
| 137 | MAPK12 | 0.31598379 |
| 138 | CDK7 | 0.31457659 |
| 139 | TTK | 0.29529198 |
| 140 | MAPKAPK2 | 0.29516638 |
| 141 | PDK2 | 0.28908653 |
| 142 | AKT2 | 0.28503636 |
| 143 | TLK1 | 0.28501591 |
| 144 | MAP3K5 | 0.27237882 |
| 145 | BRAF | 0.25720850 |
| 146 | ZAK | 0.24786376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.71405380 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.57542029 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.75406856 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.58143567 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.50770479 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.22622613 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.20376272 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.19334950 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 1.95446055 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.94536684 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.93112249 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.81750790 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81487187 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.69782994 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.68973576 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.57962038 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.57562018 |
| 18 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.52615539 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50436011 |
| 20 | Apoptosis_Homo sapiens_hsa04210 | 1.48952625 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.34300093 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.33974591 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.32538461 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31301811 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.30392574 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.26397237 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.25970410 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.25148230 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.23742299 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.21621961 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.19204329 |
| 32 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.15800503 |
| 33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.15251591 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.15165924 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.15162504 |
| 36 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.10040686 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07781545 |
| 38 | Malaria_Homo sapiens_hsa05144 | 1.04639111 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04576994 |
| 40 | Lysine degradation_Homo sapiens_hsa00310 | 1.03858959 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.00004845 |
| 42 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.99333372 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99244286 |
| 44 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.98617395 |
| 45 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.98501955 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97413835 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97154804 |
| 48 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95815588 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94588854 |
| 50 | Measles_Homo sapiens_hsa05162 | 0.91674009 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 0.87732241 |
| 52 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.87122368 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86900244 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85925564 |
| 55 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85634642 |
| 56 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85600227 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84639369 |
| 58 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.83443774 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82037688 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81978286 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81005229 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80694265 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79689501 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.79368427 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79045679 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78677074 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77045354 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.76742256 |
| 69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.76133784 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.75929620 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72885565 |
| 72 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71123911 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70842528 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.70667675 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70631276 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70564722 |
| 77 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70492743 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70322773 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69410524 |
| 80 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.69363303 |
| 81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.69361417 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.68952280 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68023766 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.67916272 |
| 85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.67862190 |
| 86 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66100071 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65910278 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65767975 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65353992 |
| 90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.64585517 |
| 91 | Base excision repair_Homo sapiens_hsa03410 | 0.64449416 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.64016778 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63421013 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63050353 |
| 95 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62970277 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62745306 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.62289090 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61202746 |
| 99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59805463 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58312271 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.57957068 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57924196 |
| 103 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57230216 |
| 104 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56332567 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55884870 |
| 106 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55443535 |
| 107 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54472027 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54110554 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.53761056 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53636451 |
| 111 | Sulfur relay system_Homo sapiens_hsa04122 | 0.53088092 |
| 112 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52411731 |
| 113 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52101357 |
| 114 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51747461 |
| 115 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51490724 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.51137932 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50626087 |
| 118 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.48951372 |
| 119 | Salmonella infection_Homo sapiens_hsa05132 | 0.48633543 |
| 120 | DNA replication_Homo sapiens_hsa03030 | 0.48625478 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44730093 |
| 122 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44203112 |
| 123 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40921541 |
| 124 | Glioma_Homo sapiens_hsa05214 | 0.40342061 |
| 125 | Focal adhesion_Homo sapiens_hsa04510 | 0.38004597 |

